NewslettersNeural Cell News Combined MEK and JAK/STAT3 Pathway Inhibition Effectively Decreases SHH Medulloblastoma Tumor Progression By lbeveridge - July 15, 2022 0 Scientists demonstrated that the MEK inhibitor, selumetinib, decreased human Sonic Hedgehog medulloblastoma growth while extending survival in mouse models. [Communications Biology] Full Article